Ekvasis of Atorvastatin (Antorcin®) Treatment in Patients With Acute Cardiovascular Events (EKVASIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01770210
Recruitment Status : Completed
First Posted : January 17, 2013
Last Update Posted : August 19, 2014
Information provided by (Responsible Party):
Elpen Pharmaceutical Co. Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2014
  Study Completion Date : July 2014
S Carter D Taylor. A Question of Choice: Compliance in Medicine Taking. Medicines Partnership 2003,
Guidelines of the Hellenic Society of Atherosclerosis for the diagnosis and treatment of dyslipidemia M. Elisaf, Ch. Pitsavos, E. Liberopoulos, V. Athyros Hellenic Journal of Atherosclerosis 2(3):163-168, 06/04/2011